Home › Compare › TCBPW vs ORCC

TCBPW vs ORCC: Dividend Comparison 2026

TCBPW yields 33333.33% · ORCC yields 9.79%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 TCBPW wins by $8.428195308647591e+21M in total portfolio value
10 years
TCBPW
TCBPW
● Live price
33333.33%
Share price
$0.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$8.428195308647591e+21M
Annual income
$8,378,748,509,141,157,000,000,000,000.00
Full TCBPW calculator →
ORCC
ORCC
● Live price
9.79%
Share price
$13.48
Annual div
$1.32
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.4K
Annual income
$1.04
Full ORCC calculator →

Portfolio growth — TCBPW vs ORCC

📍 TCBPW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTCBPWORCC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TCBPW + ORCC cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
TCBPW pays
ORCC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TCBPW
Annual income on $10K today (after 15% tax)
$2,833,333.33/yr
After 10yr DRIP, annual income (after tax)
$7,121,936,232,769,983,000,000,000,000.00/yr
ORCC
Annual income on $10K today (after 15% tax)
$832.34/yr
After 10yr DRIP, annual income (after tax)
$0.88/yr
At 15% tax rate, TCBPW beats the other by $7,121,936,232,769,983,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TCBPW + ORCC for your $10,000?

TCBPW: 50%ORCC: 50%
100% ORCC50/50100% TCBPW
Portfolio after 10yr
$4.2140976543237957e+21M
Annual income
$4,189,374,254,570,578,700,000,000,000.00/yr
Blended yield
99.41%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ORCC right now

TCBPW
No analyst data
Altman Z
-14.7
Piotroski
3/9
ORCC
Analyst Ratings
9
Buy
4
Hold
1
Sell
Consensus: Buy
Price Target
$16.00
+18.7% upside vs current
Range: $16.00 — $16.00
Altman Z
0.5
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TCBPW buys
0
ORCC buys
0
No recent congressional trades found for TCBPW or ORCC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTCBPWORCC
Forward yield33333.33% ✓9.79%
Annual dividend / share$2.00 ✓$1.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0% ✓-50%
Portfolio after 10y$8.428195308647591e+21M$21.4K ✓
Annual income after 10y$8,378,748,509,141,157,000,000,000,000.00 ✓$1.04
Total dividends collected$8.424943808765552e+21M ✓$1.0K
Payment frequencyquarterlyquarterly
SectorStockBDC

Year-by-year: TCBPW vs ORCC ($10,000, DRIP)

YearTCBPW PortfolioTCBPW Income/yrORCC PortfolioORCC Income/yrGap
1← crossover$3,344,033$3,333,333.33$11,190$489.61+$3.33M → TCBPW
2$1,045,333,048$1,041,754,932.50$12,229$256.01+$1045.32M → TCBPW
3$305,463,295,767$304,344,789,404.97$13,216$130.74+$305463.28M → TCBPW
4$83,443,192,327,233$83,116,346,600,762.75$14,207$66.02+$83443192.31M → TCBPW
5$21,308,754,850,592,396$21,219,470,634,802,260.00$15,234$33.17+$21308754850.58M → TCBPW
6$5,087,082,937,849,453,000$5,064,282,570,159,319,000.00$16,317$16.62+$5087082937849.44M → TCBPW
7$1,135,355,897,925,379,400,000$1,129,912,719,181,880,500,000.00$17,468$8.32+$1135355897925379.50M → TCBPW
8$236,895,694,937,506,160,000,000$235,680,864,126,726,020,000,000.00$18,695$4.16+$236895694937506176.00M → TCBPW
9$46,211,962,155,546,610,000,000,000$45,958,483,761,963,480,000,000,000.00$20,006$2.08+$46211962155546607616.00M → TCBPW
10$8,428,195,308,647,591,000,000,000,000$8,378,748,509,141,157,000,000,000,000.00$21,407$1.04+$8.428195308647591e+21M → TCBPW

TCBPW vs ORCC: Complete Analysis 2026

TCBPW — Stock

TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on developing immunotherapy products based on its allogeneic gamma delta T cell platform. Its products pipeline includes OmnImmune, an unmodified cell therapy used in the treatment of acute myeloid leukemia; ImmuniStim, an unmodified cell therapy to treat COVID-19; TCB009 for the GI-tract cancer treatment; and TCB005/TCB006 that are allogeneic co-stimulatory GD-T CAR pre-clinical drug candidates would target antigens expressed on various solid tumor types. The company was founded in 2013 and is headquartered in Motherwell, the United Kingdom.

Full TCBPW Calculator →

ORCC — BDC

Owl Rock Capital Corporation is a business development company. The fund makes investments in senior secured or unsecured loans, subordinated loans or mezzanine loans and also considers equity-related securities including warrants and preferred stocks also pursues preferred equity investments and common equity investments. Within private equity, it seeks to invest in growth, acquisitions, market or product expansion, refinancings and recapitalizations. It seeks to invest in middle market companies based in the United States, with EBITDA between $10 million and $250 million annually and/or annual revenue of $50 million and $2.5 billion at the time of investment.

Full ORCC Calculator →
📬

Get this TCBPW vs ORCC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TCBPW vs SCHDTCBPW vs JEPITCBPW vs OTCBPW vs KOTCBPW vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.